Cognitive Deficits in Schizophrenia and Alcoholism: A Review of the Evidence and Findings on the Effects of Treatment on Cognitive Functioning in Patients With Dual Diagnoses

被引:4
作者
Ralevski, Elizabeth [1 ]
Gianoli, Mayumi O. [1 ]
Russo, Melanie [1 ]
Dwan, Rita [1 ]
Radhakrishnan, Rajiv [1 ]
机构
[1] Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA
关键词
dual diagnosis; schizophrenia; alcohol dependence; alcohol use disorders; cognitive functioning; treatment; GLYCINE TRANSPORT INHIBITORS; HALSTEAD CATEGORY TEST; SUBSTANCE-ABUSE; CHOLINESTERASE-INHIBITORS; NEUROCOGNITIVE FUNCTION; SOCIAL COGNITION; MEMORY FUNCTION; IMPAIRMENT; METAANALYSIS; DYSFUNCTION;
D O I
10.1080/15504263.2012.696534
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: Although cognitive deficits have been carefully studied in both schizophrenia disorders and alcohol use disorders, comparatively little is known about cognitive deficits in patients with dual diagnoses of schizophrenia and alcohol use disorders. The main objectives of this article are (a) to review the literature on cognitive functioning in patients with dual diagnoses of schizophrenia and alcohol use disorders, and (b) to summarize the studies that have examined the effects of treatments on cognitive functioning in patients with these dual diagnoses. Methods: We identified and reviewed 10 studies that examined cognitive functioning in patients with schizophrenia and alcohol use disorders. We also identified and reviewed three studies that reported on treatments for cognitive deficits in patients with dual diagnoses of schizophrenia and alcohol use disorders. Results: Overall, patients with dual diagnoses of schizophrenia and alcohol use disorders were more cognitively impaired than those with a single diagnosis of schizophrenia or alcohol use disorders. The literature on the effects of treatment on cognitive functioning in patients with dual diagnoses is very limited, and the results indicate no effects of pharmacological treatments on cognitive functioning despite improvement in psychotic symptoms and/or abstinence from alcohol. Conclusions: There is a need for more systemic and rigorous study of cognitive deficits and their treatments in patients with dual diagnoses of schizophrenia and alcohol use disorders. (Journal of Dual Diagnosis, 8: 205-217, 2012)
引用
收藏
页码:205 / 217
页数:13
相关论文
共 50 条
  • [41] Volumetric abnormalities associated with cognitive deficits in patients with schizophrenia
    Wolf, Robert Christian
    Hoese, Annett
    Frasch, Karel
    Walter, Henrik
    Vasic, Nenad
    EUROPEAN PSYCHIATRY, 2008, 23 (08) : 541 - 548
  • [42] Increased plasma asymmetric dimethylarginine is associated with cognitive deficits in patients with schizophrenia
    Yang, Yuan-Jian
    Xiong, Jian-Wen
    Zhao, Ying
    Zhan, Jin-Qiong
    Chen, Hai-Bo
    Yan, Kun
    Hu, Mao-Rong
    Yu, Bin
    Wei, Bo
    PSYCHIATRY RESEARCH, 2016, 246 : 480 - 484
  • [43] Brain Structural Correlates of Cognitive Functioning in Treatment-resistant Schizophrenia Patients
    Wannan, Cassandra M. J.
    Bartholomeusz, Cali F.
    Everall, Ian
    Rahm, Christoffer
    Lieblich, Samuel
    Phassouliotis, Christina
    Vanessa, Cropley
    Pantelis, Christos
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 365S - 365S
  • [44] Non-pharmacological interventions to improve cognitive impairment and psychosocial functioning in schizophrenia: a critical review
    Nibbio, Gabriele
    Pinton, Irene Calzavara
    Bertoni, Lorenzo
    Cicale, Andrea
    Necchini, Nicola
    Zardini, Daniela
    Poddighe, Laura
    Lisoni, Jacopo
    Deste, Giacomo
    Barlati, Stefano
    Vita, Antonio
    JOURNAL OF PSYCHOPATHOLOGY, 2024, 30 (01): : 23 - 30
  • [45] Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis
    Zheng, Wei
    Xiang, Ying-Qiang
    Li, Xian-Bin
    Ungvari, Gabor S.
    Chiu, Helen F. K.
    Sun, Feng
    D'Arcy, Carl
    Meng, Xiangfei
    Xiang, Yu-Tao
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2016, 31 (04) : 286 - 295
  • [46] Approaches to Cognitive Remediation of Neuropsychological Deficits in Schizophrenia: A Review and Meta-Analysis
    Matthew M. Kurtz
    Paul J. Moberg
    Ruben C. Gur
    Raquel E. Gur
    Neuropsychology Review, 2001, 11 : 197 - 210
  • [47] Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings
    Hilverda, Karen
    Bosma, Ingeborg
    Heimans, Jan J.
    Postma, Tjeerd J.
    Vandertop, W. Peter
    Slotman, Ben J.
    Buter, Jan
    Reijneveld, Jaap C.
    Klein, Martin
    JOURNAL OF NEURO-ONCOLOGY, 2010, 97 (01) : 89 - 94
  • [48] Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings
    Karen Hilverda
    Ingeborg Bosma
    Jan J. Heimans
    Tjeerd J. Postma
    W. Peter Vandertop
    Ben J. Slotman
    Jan Buter
    Jaap C. Reijneveld
    Martin Klein
    Journal of Neuro-Oncology, 2010, 97 : 89 - 94
  • [49] Histories of childhood maltreatment in schizophrenia: Relationships with premorbid functioning, symptomatology, and cognitive deficits
    Schenkel, LS
    Spaulding, WD
    DiLillo, D
    Silverstein, SM
    SCHIZOPHRENIA RESEARCH, 2005, 76 (2-3) : 273 - 286
  • [50] Does cannabis affect cognitive functioning in patients with schizophrenia?
    Rachid, Hajar
    Saif, Zineb
    Raoui, Salma
    Serhier, Zineb
    Agoub, Mohamed
    SCHIZOPHRENIA RESEARCH-COGNITION, 2024, 36